Stock exchanges & markets

Overview Watchlists

Galderma wins EU approval for Restylane Shaype chin augmentation filler

11. Aug 2026

(AWP Alliance News) - Galderma secured EU clearance for Restylane Shaype under the Medical Device Regulation for temporary chin augmentation. The hyaluronic acid injectable is designed for deep injection to shape on bone, targeting lower-face structural enhancement without surgery.

The product already holds approvals in Canada and Brazil.

https://www.publicnow.com/view/30221F77BC44F04F5B63B4227E2D5E7782D3AF95…

Disclaimer: This news brief was created using generative artificial intelligence. Galderma Group AG published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • ETF Compass

    Stock exchanges & markets

    ETFs are becoming increasingly popular. Our ETF Compass helps you maintain an overview. Filter by criteria such as asset class, region, rating, return or costs. 

    Try the ETF Compass now

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now